Solid Biosciences (NASDAQ:SLDB) Price Target Lowered to $17.00 at Piper Sandler
Solid Biosciences (NASDAQ:SLDB – Free Report) had its target price decreased by Piper Sandler from $20.00 to $17.00 in a research report report published on Friday morning,Benzinga reports. Piper Sandler currently has an overweight rating on the stock. A number of other research analysts have also recently commented on SLDB. Wedbush dropped their price target […]
Solid Biosciences (NASDAQ:SLDB – Free Report) had its target price decreased by Piper Sandler from $20.00 to $17.00 in a research report report published on Friday morning,Benzinga reports. Piper Sandler currently has an overweight rating on the stock. A number of other research analysts have also recently commented on SLDB. Wedbush dropped their price target […]
